16:34 EST Spyre Therapeutics files to sell 12M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SYRE:
- Spyre Therapeutics initiated with a Buy at BTIG
- Spyre Therapeutics price target raised to $27 from $23 at Stifel
- Spyre Therapeutics initiated with bullish view at Jefferies, here’s why
- Nike upgraded, Paramount downgraded: Wall Street’s top analyst calls
- Guggenheim starts Spyre Therapeutics with a Buy on ‘best-in-class’ IBD potential